Most participants in clinical trials lost 1-2% of body weight during this initial month, primarily from the modest GLP-1 activation reducing caloric intake slightly
Whether the same outcome generalizes to compounded or research-peptide retatrutide is an open question
Many patients struggle to reach the highest doses due to side effects or adherence issues
These foods provide essential amino acids that help maintain muscle mass and support metabolism and cognitive function while appetite is reduced
In comparison, weight loss drugs Wegovy, Ozempic and Mounjaro only work on the and GIP and GLP-1 receptor agonist
These agents, which have shown efficacy in non-transplant populations, present new opportunities for improving the management of diabetes mellitus in liver transplant recipients, potentially mitigating the adverse effects of PTDM and enhancing long-term outcomes